These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36871242)

  • 41. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients.
    de Jonge E; van der Vooren M; Gillis JMEP; Del Prado MR; Wigbers J; Bakhshi-Raiez F; Elzo Kraemer CV
    J Nephrol; 2023 May; 36(4):1019-1026. PubMed ID: 36342643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB
    Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of outcome in non-septic critically ill patients with acute kidney injury on continuous venovenous hemofiltration.
    Koning MV; Roest AA; Vervloet MG; Groeneveld AB; Nurmohamed SA
    Nephron Extra; 2011 Jan; 1(1):91-100. PubMed ID: 22470383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review.
    Brunoni B; Zadek F; Mulazzani F; Verza G; Marrazzo F; Spina S; Protti A; Fumagalli R; Langer T
    Blood Purif; 2023; 52(9-10):802-811. PubMed ID: 37673054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticoagulant effect of low concentration plasma trisodium citrate in continuous veno-venous hemofiltration.
    Long J; Li Z; Zhang Z; Dong X; Zhu C
    Ann Palliat Med; 2021 Aug; 10(8):8900-8908. PubMed ID: 34488377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Citrate anticoagulation during CVVH in high risk bleeding patients.
    Cubattoli L; Teruzzi M; Cormio M; Lampati L; Pesenti A
    Int J Artif Organs; 2007 Mar; 30(3):244-52. PubMed ID: 17417764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crush syndrome after the Wenchuan earthquake: new experience with regional citrate anticoagulation continuous veno-venous hemofiltration.
    Xie HL; Ji DX; Hu WX; Wu Y; Ge YC; Hou JH; Li LS; Liu ZH
    Int J Artif Organs; 2010 Feb; 33(2):114-22. PubMed ID: 20306438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury.
    Schilder L; Nurmohamed SA; ter Wee PM; Girbes AR; Beishuizen A; Paauw NJ; Beelen RH; Groeneveld AB
    Cytokine; 2012 Dec; 60(3):601-7. PubMed ID: 23006672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration.
    Wang P; Xing H; Zhang F; Liu S; Lu Y; Zhang X; Yang J; Sun T
    Int J Antimicrob Agents; 2022 Jul; 60(1):106599. PubMed ID: 35526750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
    Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
    Clin Transl Sci; 2020 Sep; 13(5):950-959. PubMed ID: 32223067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example.
    Jager NGL; Van Ewijk-Beneken Kolmer E; Aarnoutse R; Te Brake LHM
    J Antimicrob Chemother; 2024 May; 79(5):1187-1190. PubMed ID: 38569058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution.
    Jeffrey YH; Hoi-Ping S; Kit Hung AL; Chung-Ling L; Wing-Wa Y; King-Yiu L
    Indian J Crit Care Med; 2017 Jan; 21(1):11-16. PubMed ID: 28197045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN; Haroon SWP; Mukhopadhyay A; Lau T; Murali TM; Phua J; Tan ZY; Lee N; Chua HR
    J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.